Martica Enterprises

Martica Pharmaceuticals is a pre-clinical stage biotechnology company focused on developing novel senolytic therapies to treat age-related diseases and cancer. The company's research centers on the selective elimination of senescent cells, which accumulate with age and contribute to chronic inflammation and tissue dysfunction. By targeting these "zombie cells," Martica aims to restore tissue homeostasis and improve outcomes in indications such as fibrosis and various oncology settings. The company leverages insights into the molecular pathways that govern cellular senescence to design high-precision small molecule interventions.